|
|
|
Press Release: PCF Pharma Compliance Congress XIX Features FCPA Enforcement Update
|
- Sponsored by the Pharmaceutical Compliance Forum
- November 7 - 9, 2018
- Onsite at the Mandarin Oriental, Washington, DC
- Online in Your Own Office or Home Live via the Internet with 24/7 Access for Six Months
- Media Partners: Harvard Health Policy Review, Health Affairs and Life Sciences Compliance Update
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: registration@hcconferences.com
Website: www.PharmaCongress.com |
EARLY BIRD REGISTRATION
- SAVE UP TO $400 -
|
Register by Friday, September 21, 2018 and save up to $400.
Click here to register.
|
|
|
FEATURING FCPA ENFORCEMENT UPDATE BY
|
Leslie Backschies, MA
Supervisor Special Agent and Unit Chief, International Corruption Unit, Federal Bureau of Investigation, Los Angeles, CA |
Jacob Elberg, JD
Assistant US Attorney, US Attorney's Office, District of New Jersey, US Department of Justice, Newark, NJ |
Tarek Helou, JD
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
|
Cheryl J. Scarboro, JD
Partner, Simpson Thacher & Bartlett; Former Chief, Foreign Corrupt Practices Act Unit, Enforcement Division, US Securities and Exchange Commission, Washington, DC |
Gary F. Giampetruzzi, JD
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA (Moderator)
|
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 29, 2018: The Pharmaceutical Compliance Forum's Nineteenth Pharmaceutical and Medical Device Compliance Congress, www.PharmaCongress.com, will be held November 7 - 9, 2018 at the Mandarin Oriental in Washington, DC. Registrants may attend the event in person or online (live webcast and archived for 6 months).
|
|
KEYNOTE SPEAKERS
|
Thomas W. Abrams, RPh, MBA
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD |
Leslie Backschies, MA
Supervisor Special Agent and Unit Chief, International Corruption Unit, Federal Bureau of Investigation, Los Angeles, CA |
Richard Bistrong, MA
Chief Executive Officer, Front-Line Anti-Bribery LLC, Contributing Editor, FCPA Blog, Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ, Former Cooperating Witness, City of London Police, HMRC and CPS, UK, New York, NY, USA
|
Susan Dentzer
President and Chief Executive Officer, NEHI, (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Former Editor, Health Affairs, Washington, DC |
Jacob Elberg, JD
Assistant US Attorney, US Attorney's Office, District of New Jersey, US Department of Justice, Newark, NJ |
Christopher B. Harwood, JD
Assistant US Attorney and Chief of the Civil Health Care Fraud Unit, US Attorney's Office, Southern District of New York, Former Assistant US. Attorney, US Attorney's Office for the District of Columbia, US Department of Justice, New York, NY
|
Tarek Helou, Esq.
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC |
Rachael Honig, JD
First Assistant US Attorney, US Attorney's Office for the District of New Jersey, Former Corporate Counsel, Litigation, Celgene, New York, NY |
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC
|
Gregg Shapiro, JD
Assistant US Attorney, US Attorney's Office, District of Massachusetts, US Department of Justice, Boston, MA |
Sally Q. Yates, JD
Partner, King and Spalding, Former Acting Attorney General, Former Deputy Attorney General, Former Assistant US Attorney, US Attorney's Office, Northern District of Georgia, US Department of Justice, Washington, DC
|
|
|
AGENDA-AT-A-GLANCE
|
|
FEATURING AN INVITATION-ONLY CCO ROUNDTABLE
|
- Hosted by the PCF and the PhRMA CCO Working Group
|
|
PRECONFERENCE SESSIONS
|
- Patient Support Programs: Risk and Risk Management Best Practices
- Practical Approaches to Handling Investigations
- Advanced Strategies in Auditing and Monitoring
- Advanced Strategies for the Use of Data Analytics in Compliance Programs
|
|
PLENARY SESSIONS
|
- C-Suite Keynote Address
- OIG Update Keynote Address
- FDA Keynote Address
- Sally Yates Keynote Address
- DOJ, FBI and SEC FCPA Enforcement Update
- Annual AUSA Roundtable
- Annual Qui Tam Roundtable
- Annual Chief Compliance Officer Roundtable
- The Hidden Risks Your Risk Assessment Might Miss
- Patient Support Programs Roundtable
- Recent Developments in Pharmaceutical and Medical Device Pricing and Cost Containment
|
|
PHARMA CONGRESS IS
|
|
|
|
|
MINI SUMMITS
|
- Fostering a Culture of Ethics and Compliance
- Global Compliance Function Harmonization
- Third Party Lifecycle Management
- Annual Medical Device Compliance Roundtable
- Compliance for Small to Mid-size Pharma and Device Companies
- Advanced Strategies to Measure Effectiveness, Monitor and Report
- The Evolution of Promotional Programs
- Open Payments: Where Does the Sun Shine Now?
- Interactions with Specialty Pharmacy
- Is your Board of Directors Bored of your Compliance Dashboards?
- Next Generation Data Analytics
- R&D: Hidden Risks beyond Clinical Trail Recruitment
- Market Access Compliance Considerations
- Promotion with Medical Professionals: Avoiding White Coat Marketing
- Dissecting Recent CIAs and Review of Draft Model CIA
- Compliance Issues Associated with PBM Relationships
- Risk Assessments and Mitigation Plans
- "All in Compliance" - Aligning with Your Business Partners
- Navigating the Murky Waters of Patient Programs
- Compliance for "Evolved" Products, including Aesthetics and Gene Therapy
- Best Practice in HCP/HCO Management
- Compliance Considerations in Value-based Contracting
- An Interactive Case Study in Effective Crisis Management
- Privacy and Cybersecurity Compliance Update, including GDPR
- The Compliance Training Revolution
|
|
AND DAY III INDUSTRY-ONLY PLENARY ROUNDTABLE
|
- Featuring AUSA Gregg Shapiro, JD
|
|
|
FEATURED FACULTY
|
James Accumanno, JD
Director Risk, Monitoring and Auditing, Novo Nordisk, Former Associate Counsel, Bayer, Philadelphia, PA |
Eliza L. Andonova, JD
Counsel, Hogan Lovells, Washington, DC |
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former VP, Chief Compliance Officer, Dendreon, Chicago, IL |
Eric Baim, JD
Managing Director, Dovetail Consulting Group, LLC, Former VP, Head of US Compliance, Shire, Boston, MA
|
Minna Bak, MBA
Senior Manager, Helio Health Group, New York, NY |
Ann Beasley, JD
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Former Senior Vice President, Chief Compliance Officer, Biogen, Boston, MA |
Thomas Beimers, JD
Partner, Hogan Lovells, Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Former Special Assistant United States Attorney, US Attorney's Office, Eastern District of Michigan, Minneapolis, MN and Washington, DC |
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC
|
Brian A. Bohnenkamp, MHA, JD
Partner, FDA & Life Sciences Practice, King & Spalding LLP, Washington, DC |
Kathleen Boozang
Dean and Professor of Law at Seton Hall Law, Newark, NJ |
Christine N. Bradshaw, JD
Vice President, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ |
Julianne Brierley
Director, Head of Compliance Learning, Novartis, New York, NY
|
Katherine Buckley, MBA
Partner, Pharmaceutical and Life Sciences Advisory Practice, PwC, Philadelphia, PA |
Ed Buthusiem, JD
Managing Director, Berkeley Research Group, Adjunct Professor Of Law, Temple University, Former SVP, R&D Legal Operations & Vaccines, GSK, Devon, PA |
Joseph Calarco
Chief Compliance Officer at Neos Therapeutics, Inc., Philadelphia, PA |
Christie Camelio
Vice President and US Healthcare Compliance Officer, Celgene, Former Head of Risk Management, Novartis, Summit, NJ
|
Regina G. Cavaliere, JD
Principal, Regulatory Enforcement & Compliance, Life Sciences Sector, KPMG LLP, Former Vice President and Chief Compliance Officer, Otsuka America, Short Hills, NJ |
Nicole Chandonnet, JD
Associate, Covington & Burling, Washington, DC |
Brian Conner
Vice President, Head of Corporate Compliance, Strongbridge Biopharma plc, Trevose, PA |
Thomas Costa, JD
Member, US Board of Directors, Sanofi; Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC
|
Clarissa Crain
Senior Manager, Life Sciences Advisory, Deloitte, Philadelphia, PA |
Zachary A. Cunha, JD
Assistant US Attorney and Chief, Civil Division, US Attorney's Office, District of Rhode Island, US Department of Justice, Former AUSA, District of Massachusetts and Eastern District of New York, Providence, RI |
Jill Dailey, MBA, JD
Vice President & Chief Compliance Officer, Incyte, Former AG, Asia Pac Lead, Pfizer, Former Head, US Ethics and Compliance, Novartis, New York, NY |
Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL
|
Mahnu V. Davar, JD
Partner, Arnold & Porter Kaye Scholer LLP, Lecturer, University of Pennsylvania Law School, Fellow, Salzburg Global Seminar, Washington, DC |
BJ D'Avella
Senior Manager, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, Atlanta, GA |
Gary Del Vecchio
Health Care CO Cardiovascular & Metabolism, The Janssen Pharmaceutical Companies of Johnson & Johnson, Former EDi US Pharmac Compliance & Ethics, Bristol-Myers Squibb, Former PCF Co-chair, New York, NY |
Mark A. DeWyngaert, MBA, PhD
Managing Director, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY
|
Sarah diFrancesca, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY |
Stefanie A. Doebler, JD
Of Counsel, Covington & Burling LLP, Washington, DC |
Suzanne E. Durrell, JD
Partner, Whistleblower Law Collaborative, Taxpayers Against Fraud Education Fund, 2017 Whistleblower Lawyer of the Year, Boston, MA |
Michael Dusseau
Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, Madison, NJ
|
Eileen Erdos
Principal, Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL |
Jill Fallows-Macaluso, JD
Chief Compliance Officer and Vice President, Novo-Nordisk, Princeton, NJ |
Margaret Feltz, JD, MA
Vice President, Ethics and Compliance, Purdue Pharma LP, Former PCF Co-chair, Stamford, CN |
Alison Fethke, JD
Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL
|
Kellie Fidler, MBA, PMP
Director, Global Compliance Risk Mitigation & Monitoring Strategy, Bristol-Myers Squibb, Princeton Pike, NJ |
Francisco Ribeiro Filho, MBA
Senior Director & Head of US Compliance, Tesaro, Inc., Former Sr. Director, Corporate Compliance, Biogen, Former Sr. Director, International Markets, Sandoz, Former Sr. Manager, LatAm, Johnson & Johnson, Boston, MA |
Paul Fishman, JD
Partner and Head, Crisis Management and Strategic Response Team, Arnold & Porter LLP, Former United States Attorney, District of New Jersey, Washington, DC |
Paul Flanagan, JD
Assistant Professor of Law, Thomas R. Kline School of Law, Drexel University, Former Chief Compliance and Privacy Officer, 21st Century Oncology, West Chester, PA
|
Indrani M. Lall Franchini, JD
Executive Vice President & Chief Compliance Officer, Alexion Pharmaceuticals, Inc., Former Assistant General Counsel, Pfizer, New York, NY |
Sarah A. Franklin, JD
Partner, Covington & Burling LLP, Former Attorney, Federal Trade Commission, Washington, DC |
Alex Ganz, JD
Senior Manager of Compliance, Aegerion Pharmaceuticals, Former Compliance Manager, Shire and Vertex, Boston, MA |
Nereyda Garcia, JD
Global Heath, Ethics and Compliance, Alnylam Pharmaceuticals, Former Sr. Director, Compliance, Biogen Idec, Cambridge, MA
|
Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY |
Virginia "Ginny" A. Gibson, JD
Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA |
Jonathan Glazier, JD, MBA
Head of Legal Compliance, Philips North America LLC, Former Senior Director of Corporate Compliance and Privacy Officer, Fresenius Medical Care North America, Andover, MA |
Wendy C. Goldstein, JD
Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY
|
Anthony Greco, MBA
Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA |
Lillian S. Hardy, JD
Partner, Hogan Lovells LLP, Washington, DC |
Patricia J. Harned, PhD
Chief Executive Officer, ECI (Ethics and Compliance Initiative), Former President, Ethics Resource Center, Washington, DC |
Kate Heinzelman, JD
Counsel, Sidley Austin LLP, Former Deputy GC, US DHHS, Former Special Assistant and Associate Counsel, President Barack Obama, Washington, DC
|
Laura G. Hoey, JD
Co-leader, Government Enforcement and White Collar Group and Health Care and Life Sciences Industry Group, Ropes & Gray LLP, Boston, MA |
Christine Hood
Director, Learning and Development, Chiesi, Former District Sales Manager, Boehringer Ingelheim, Former Sales Trainer, Biovail, Apex, NC |
Casey J. Horton, CFE
Director, Life Sciences, Governance, Risk & Compliance, Navigant, Chicago, IL |
Becky Hsiao, JD
Senior Legal Manager, Americas Region, Diabetes Group, Medtronic, Los Angeles, CA
|
Emily Huebener, MA
Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL |
Michael Joachim, JD
Global Business Partner, Ethics & Business Integrity, Sanofi Genzyme, Cambridge, MA |
Elizabeth Jobes, JD
Head of Corporate Compliance and Legal Counsel, Spark Therapeutics, Inc., Former Senior VP & CCO, Auxilium, Former Chief, Repeat Offender Unit, Philadelphia DA's Office, Philadelphia, PA |
Darren R. Jones
Partner, Global Compliance Consulting Leader, Polaris Management, New York, NY
|
Marci Juneau, MBA
Partner, Helio Health Group, Atlanta, GA |
Jonathon Kellerman
Executive Vice President, Global Chief Compliance Officer, Allergan PLC, Former Partner, PwC, Parsippany, NJ |
Kiley Smith Kelly, MBA
Partner, Forensic and Integrity Services, Ernst & Young LLP, Philadelphia, PA |
Daryl Kreml, JD
Vice President & Chief Compliance Officer, SageTherapeutics, Former Head, US Compliance & Global Program Management, Biogen, Former Director & Sen Managing Counsel, Int'l Compliance, Boston Scientific, Boston, MA
|
Bharathram Lakshmivarahan, MBA
Life Sciences Strategy & Operations Consultant, PwC, San Francisco, CA |
Puja Leekha, JD
Vice President, Chief Compliance Officer and Corporate Counsel, Corporate Compliance, Lundbeck Pharmaceuticals LLC, Former Division Legal Counsel & Compliance Officer, Stryker Corporation, Deerfield, IL |
Marc Levine
Director of Compliance, Insightec, Former Compliance Officer, Stryker Corporation, Former Business Conduct Specialist, MAKO Surgical, Fort Lauderdale, FL |
Jodi Lindsey, JD
Senior Director & Head of US Healthcare Compliance, Alkermes, Former Associate Director, Commercial Compliance, Biogen, Boston, MA
|
Pamela Lonzer, MSJ
Associate Director, Medical Operations, Compliance & Controls, Alexion, Former Assoc Director-US Medical Advisor, Global Compliance & Risk Management, Shire, Former Ass Director, Research and Development-Global Compliance, Astellas, Chicago, IL |
Joe Mack, JD
Senior Compliance Counsel, Bayer, Former Assistant United States Attorney and Deputy Chief, Health Care and Government Fraud Unit, US Attorney's Office, District of New Jersey, New York, NY |
Colette G. Matzzie, JD
Partner, Phillips & Cohen LLP, Former Staff Attorney, Public Citizen Litigation Group, Former Trial Attorney, Tobacco Litigation Team, US Department of Justice, Washington, DC |
Vickie L. McCormick
Vice President, Janssen U.S. Commercial Health, Care Compliance & CIA Operations, Johnson & Johnson, Former Chief Compliance Officer, St. Jude Medical, Titusville, NJ
|
Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD |
Jean McKiernan, MBA
Director, Pharmaceutical and Life Sciences Advisory Practice, PwC, Chicago, IL |
Jason P. Mehta, JD
Partner, Bradley Arant Boult Cummings LLP, Former Assistant United States Attorney, US Attorney's Office for the Middle District of Florida, US Department of Justice, Tampa, FL |
Kathleen Meriwether, JD
Principal, Fraud Investigation and Dispute Services, EY, Former Assistant United States Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA
|
Brian Miller, PhD
Director Compliance Training and Documentation, Otsuka, Former Senior Manager of Learning Technologies, AstraZeneca, Former Associate Director Learning Design & Technology, Merck, Princeton, NJ |
Vahan Minassian, JD
Director, US Promotional Monitoring Lead, Pfizer, Philadelphia, PA |
Melissa Murphy, MBA
Senior Compliance Specialist, Office of Ethics & Compliance, Medtronic, Minneapolis, MN |
Katherine Cartwright Norris, MPA
Director, Berkeley Research Group, Former Senior Director, Compliance, NSF Health Sciences, Former Director, Corporate Compliance, Spectranetics, Washington, DC
|
Adam Oakley
Director, Potomac River Partners, Arlington, VA |
Agatha O'Malley, MStPH, JD
Privacy Officer and Senior Counsel, Otsuka Pharmaceuticals (US), Former Director - Head of Privacy, Shire, Philadelphia, PA |
John Patrick Oroho, JD
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ |
Amy Pawloski
Compliance Officer - Operations at Endo Pharmaceuticals, Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA
|
Joe Philipose, JD
Vice President, US & Enterprise Compliance, Alexion, Former Director of Compliance, Salix, Former Director, PwC Life Sciences Consulting, Boston, MA |
Perri Pomper
Director - Ethics and Compliance Strategy & Education at Novo Nordisk |
Lori Queisser
Senior Vice President and Global Chief Compliance Officer, Teva, Former Sr. VP Global Compliance & Business Practices, Schering-Plough, Former VP & CCO, Eli Lilly, Former Co-chair, PCF, Horsham, PA |
Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC
|
Jeffrey Rosenbaum, MBA
Partner and Co-founder, Dovetail Consulting Group, LLC, Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA |
David Ryan, JD
Vice President and Chief Compliance Officer, Epizyme, Former Vice President, Associate GC and CCO, Haemonetics, Former Vice President of Legal Affairs, Assistant General Counsel and CCO, AMAG Pharmaceuticals, Boston, MA |
Cheryl J. Scarboro, JD
Partner, Simpson Thacher & Bartlett, Former, Chief, Foreign Corrupt Practices Act Unit, Enforcement Division, US Securities and Exchange Commission, Washington, DC |
Sue Seferian, JD
Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ
|
George Serafin, MS
National Health Care and Life Sciences Leader, Grant Thornton, LLP, Iselin, NJ |
Michael Shaw, JD
Vice President and Compliance Officer, US Pharmaceuticals, GlaxoSmithKline, Former Senior Counsel, Office of Inspector General, US DHHS, Former PCF Co-chair, Philadelphia, PA |
Paul Silver
Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA |
Laura (Munns) Skinner, MBA
Senior Manager, Life Sciences Advisory, Deloitte, Austin, TX
|
John Smollen, MA, JD
Practice Professor of Law and Director, Center for Compliance and Ethics, Temple Law, Former EVP and CCO, Endo International, Philadelphia, PA |
Eugene F. Soltes, MBA, PhD
Jakurski Family Associate Professor of Business Administration, Harvard Business School, Author, Why They Do It: Inside the Mind of the White-Collar Criminal, Cambridge, MA |
Oliver Steck
Principal, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY |
Silvija A. Strikis, JD
Partner, Kellogg Hansen Todd, Figel & Frederick, Former Law Clerk, Justice Sandra Day O'Connor, US Supreme Court, Washington, DC
|
Ann-Marie Tejcek, MA
Senior Director, Ethics & Compliance, Eli Lilly and Company, Indianapolis, IN |
Yuet Ming Tham, JD
Partner and Global Head of White Collar Group, Sidley Austin, LLP, Former Asia Pacific Regional Compliance Director, Pfizer, Former Deputy Public Prosecutor, Singapore, Singapore and Hong Kong |
Bryan Timer, MA Business Analytics
Director, Data Analytics & Transparency, Merck, North Wales, PA |
Brian Van Hoy
Vice President, G&M Health LLC, Former Director, Ethics and Compliance, Eli Lilly, Bridgewater, NJ
|
Jennifer Vondee, MPH
Manager, Pharmaceutical & Life Sciences Risk Consulting, PwC, Durham, NC |
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services; Washington, DC |
Lisa Walkush, EMTM
Partner, Grant Thornton, LLP, Philadelphia, PA |
William Weinreb, JD
Partner, Quinn Emanuel, Former Acting United States Attorney and First Assistant US Attorney, Boston, Boston, MA
|
Sarah Whipple, JD
Senior Corporate and Compliance Counsel, Akebia Therapeutics, Inc., Former VP, Global Compliance & Privacy Officer, Aegerion, Former CCO and Assoc. GC, AMAG, Boston, MA |
Donna White
Vice President, Contracts & Compliance, Chiesi USA, Inc., Former Sr. Director, Contracts and Compliance, Cornerstone Therapeutics, Cary, NC |
Seth B. Whitelaw, JD, LLM, SJD
President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, West Chester, PA |
Kathryn "Katie" E. Winson
Senior Manager, US HCC Monitoring, Celgene Corporation, Summit, NJ
|
|
|
2018 GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
TWELFTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
May 14 - 16, 2018
Hotel Savoyen
Vienna, Austria
www.International PharmaCongress.com
|
|
EIGHTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
|
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
September 10 - 12, 2018
Singapore
www.Asian PharmaCongress.com
|
|
NINETEENTH ANNUAL PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS
|
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 7 - 9, 2018
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
|
|
|
|
|
|
SPONSORED BY
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 70 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
|
|
CONGRESS CO CHAIRS
|
Michael R. Clarke, JD
Vice President, Corporate Compliance, Indivior Inc., Richmond, VA
(PCF Co-Chair)
Sujata T. Dayal, JD
Vice President, Health Care Compliance & Privacy, Pharmaceuticals Group, Johnson & Johnson, Titusville, NJ
(PCF Secretary)
Jeffrey M. Kawalek, MBA
Senior Director, Ethics & Compliance, North America, Ipsen Biopharmaceuticals, Inc., Basking Ridge, NJ
(PCF Chair)
Jennifer McGee, JD
Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD
(PCF Treasurer)
Margaret Sparks, JD
Associate Vice President, North America Ethics and Business Integrity, Sanofi US, Bridgewater, NJ
(PCF Co-Chair)
Joe Zimmerman
Vice President and Chief Compliance Officer US, Ferring Pharmaceuticals, Parsippany, NJ
(PCF Co-Chair)
|
|
GRANTORS:
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
CONTINUING EDUCATION CREDITS
|
Accounting Professionals: Approved for up to 19.0 NASBA CPE credits.
Attorneys: The Congress is currently pending approval to offer Pennsylvania MCLE Credit.
Compliance Professionals: This program will be submitted to Compliance Certification Board (CCB)® for approval of CCB CEUs.
|
|
MEDIA PARTNERS:
|
|
|
STAY CONNECTED
|
Tweet using #PharmaCongress
|
|
PARTICIPATION OPTIONS
|
|
TRADITIONAL ONSITE ATTENDANCE
|
Simply register, travel to the conference city and attend in person.
Pros: subject matter immersion; professional networking opportunities; faculty interaction
|
|
LIVE AND ARCHIVED WEBCAST PARTICIPATION
|
Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.
The archived conference includes speaker videos and coordinated PowerPoint presentations.
Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office
|
|
WEBCAST INTERFACE SAMPLE
|
Click here for a sample stream
|
|
PAST GLOBAL PHARMA COMPLIANCE CONGRESSES
|
|
2007 - Brussels
2008 - Paris
2009 - Rome
2010 - Berlin
2011 - Istanbul
2011 - Singapore
2012 - Budapest
2012 - Shanghai
2012 - São Paulo
2013 - Madrid
2013 - Kuala Lumpur
2014 - Dubai
2014 - Mexico City
2014 - Shanghai
2015 - Manila
2016 - Warsaw
2017 - Lisbon
2018 - Vienna
|
|
|
|
|
|
